Cargando…
Association Study of the Beta-Adrenergic Receptor Genetic Variant Gly389Arg and Fluoxetine Response in Major Depression
BACKGROUND: Pharmacogenetics has proven role in the treatment of different illnesses. Patients with special genotypes may achieve a better response to a specific drug. On the other hand, genetic parameters markedly contribute to the development of major depressive disorder (MDD). The significance of...
Autores principales: | Firouzabadi, Negar, Asadpour, Roja, Zomorrodian, Kamiar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Salvia Medical Sciences Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343933/ https://www.ncbi.nlm.nih.gov/pubmed/34466591 http://dx.doi.org/10.31661/gmj.v9i0.1781 |
Ejemplares similares
-
Arg389Gly β1-adrenergic receptor polymorphism and susceptibility to syncope during tilt test
por: Żelazowska, Monika, et al.
Publicado: (2014) -
Polymorphism of the Beta-1 Gly389Arg receptor in patients with dual atrioventricular nodal physiology
por: Boris, Douglas Joel, et al.
Publicado: (2020) -
Obesity is associated with the Arg389Gly ADRB1 but not with the Trp64Arg ADRB3 polymorphism in children from San Luis Potosí and León, México
por: Aradillas-García, Celia, et al.
Publicado: (2017) -
Beta-2 adrenergic receptor gene polymorphisms Gln27Glu, Arg16Gly in patients with heart failure
por: Mansur, Alfredo José, et al.
Publicado: (2009) -
Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors
por: de Paiva, Ana Carolina Zimiani, et al.
Publicado: (2014)